We believe this may be due to the low prevalence of AD pathology and APOE ε4 in our primary dataset, or alternatively the fact that DNA methylation age acceleration was measured using DNA from the frontal cortices, whereas HistoAge acceleration was quantified in the hippocampus. Here, APOE is linked to Alzheimer disease.